Viewing Study NCT01580735


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2025-12-25 @ 8:15 PM
Study NCT ID: NCT01580735
Status: COMPLETED
Last Update Posted: 2015-08-18
First Post: 2012-04-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer
Sponsor: Kyowa Kirin Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module